Clinical Trial Update: Arrhythmia Restart Prevention and RatE STabilization in Atrial Fibrillation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update sponsored by Vitatron France evaluating arrhythmia restart prevention and rate stabilization in atrial fibrillation, including sic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Brady-tachycardia Syndrome
• Sick Sinus Syndrome

Snippet

Sponsor: Vitatron France | Conditions: Sick Sinus Syndrome, Brady-Tachy Syndrome | Phase 4 | Status: UNKNOWN